Zobrazeno 1 - 10
of 253
pro vyhledávání: '"Richard C, Strange"'
Autor:
Geoffrey Hackett, Amar Mann, Ahmad Haider, Karim S. Haider, Pieter Desnerck, Carola S. König, Richard C. Strange, Sudarshan Ramachandran
Publikováno v:
The World Journal of Men's Health, Vol 42, Iss 4, Pp 749-761 (2024)
Purpose: While testosterone therapy can improve the various pathologies associated with adult-onset testosterone deficiency (TD), Summary of Product Characteristics (SPC) of five testosterone preparations caution that treatment may be associated wi
Externí odkaz:
https://doaj.org/article/e5a878eab02448e1842bd55b5b696b26
Publikováno v:
The World Journal of Men's Health, Vol 38, Iss 1, Pp 68-77 (2020)
UKPurpose: To describe the 4-year metabolic follow-up results from the BLAST study.Materials and Methods: Baseline hemoglobin A1c (HbA1c), weight, and waist circumference (WC) data were recorded in 185 men recruited for the BLAST randomised controlle
Externí odkaz:
https://doaj.org/article/c9519d98f97349e3b94a4296b2871810
Autor:
Sudarshan Ramachandran, Carola S. König, Amro Maarouf, Karim Sultan Haider, Farid Saad, Pieter Desnerck, Nathan Lorde, Geoff Hackett, Richard C. Strange, A Haider, Adeeba Ahmed
Publikováno v:
Androgens: Clinical Research and Therapeutics. 2:150-159
Copyright © Richard C. Strange et al., 2021. Objective: Testosterone therapy (TTh) may reduce morbidity/mortality in men with adult-onset testosterone deficiency (TD), though some cardiovascular safety concerns remain. Increased hematocrit (HCT), a
Autor:
Karim Sultan Haider, Farid Saad, Pieter Desnerck, Nathan Lorde, Carola S. König, Amro Maarouf, A Haider, Sudarshan Ramachandran, Geoff Hackett, Richard C. Strange
Copyright © Nathan Lorde et al., 2021. Objective: Hematocrit (HCT)/hemoglobin (Hb) ratio in (%/g/dL) is around 3, with high fidelity between measured and derived Hb (applying the conversion using HCT) in various pathologies. We examined changes in H
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::079c26285895384e064006f48950a3ff
https://eprints.keele.ac.uk/10164/1/andro.2021.0013.pdf
https://eprints.keele.ac.uk/10164/1/andro.2021.0013.pdf
Autor:
Amar Puttanna, Sudarshan Ramachandran, Abhishek Rao, Richard C. Strange, Farid Saad, Pieter Desnerck, Carola S. König, A Haider, Geoff Hackett, Karim Sultan Haider
Background: Klinefelter's syndrome (KS) is characterized by extra X chromosomes and features of primary hypogonadism including osteopenia and osteoporosis. Testosterone therapy (TTh) is widely used to treat men with KS and low serum testosterone/hypo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c707034f9b076119542ad67abc79aa1e
https://www.repository.cam.ac.uk/handle/1810/326085
https://www.repository.cam.ac.uk/handle/1810/326085
Autor:
C Lowndes, Seema Kalra, Richard C. Strange, Clive Hawkins, S. John Curnow, Lindsay Durant, A Al-Araji
Publikováno v:
Multiple Sclerosis Journal-Experimental, Translational and Clinical
Background The nature and extent of inflammation seen in multiple sclerosis (MS) varies throughout the course of the disease. Changes seen in CD4+ T-helper cells in relapsing–remitting (RR) MS and secondary progressive (SP) MS might differ qualitat
Publikováno v:
BJU International. 123:519-529
Objectives To further characterize the beneficial impact of testosterone replacement therapy (TRT) on the association between mortality and hypogonadism (HG) in men with type 2 diabetes (T2DM), by determining, firstly, if changes in cardiovascular di
Publikováno v:
Andrology. 6:846-853
BACKGROUND:\ud Serum sex hormone-binding globulin levels have been associated with mortality in adult men with type 2 diabetes (T2DM).\ud \ud OBJECTIVES:\ud To confirm the association of serum sex hormone-binding globulin with mortality and then dete
Publikováno v:
Edorium Journal of Biochemistry
No Abstract\ud \ud Keywords: Adult onset testosterone deficiency, Clinical guidelines, Laboratory performance, Testosterone therapy, Testosterone assays
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::850d0b8930ca0026e95ffa40cedf0015
Autor:
Richard C. Strange, Geoffrey Hackett, Carola S. König, Stavroula Balabani, Sudarshan Ramachandran
INTRODUCTION Clinical guidelines indicate that hematocrit should be monitored during testosterone replacement therapy (TTh), with action taken if a level of 0.54 is exceeded. AIM To consider the extent of changes in hematocrit and putative effects on
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c9fc25c6de632d7b48c6f9a1c6123b66
http://bura.brunel.ac.uk/handle/2438/20683
http://bura.brunel.ac.uk/handle/2438/20683